BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

DIREVO Industrial Biotechnology GmbH Announces Successful Closure of 3.5 Million Euro Financing Round


3/19/2013 11:21:16 AM

Cologne, Germany, March 18, 2013. Today, Direvo Industrial Biotechnology GmbH (Direvo) announced the successful closure of a financing round of three and a half million Euro to fund the sustainable growth of the company.

All current major investors participated in this third financing round since the founding of Direvo, a spin-off from Direvo Biotech AG, in the year 2008. The capital will be used to get the platform technologies BluCon® and BluZy® ready for the market.

Jorg Riesmeier, Chief Executive Officer of Direvo, said: “We are pleased to have closed this financing round to accelerate the market maturity of our products. We are also very proud that all of our existing investors have committed again. This underlines the investors’ belief in our team, the satisfaction with the things we have achieved so far and the trust to manage the up-coming challenges in the markets. Direvo is well prepared for a successful market entrance.”

About Direvo Industrial Biotechnology GmbH:

Direvo is a biotechnology company focusing on the biomass conversion industry. Direvo identifies bottlenecks and weaknesses in current industrial processes in this sector and develops and implements biology-based solutions together with large and small industrial partners. Direvo’s products are newly designed enzymes and high quality microorganisms that provide easy-to-implement and cost-effective solutions. Direvo’s contributions strengthen the competitiveness and the profitability of the partners while supporting them to make the future cleaner, greener and safer. More information about Direvo is available on www.direvo.com.

Contact:

Jorg Riesmeier

DIREVO Industrial Biotechnology GmbH

Nattermannallee 1

50829 Köln (Cologne)

Germany

Phone +49 221-47448-101

Fax +49 221-47448-111

E-Mail joerg.riesmeier@direvo.com

Internet www.direvo.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES